Cargando…
The health and economic burden of haemophilia in Belgium: a rare, expensive and challenging disease
BACKGROUND: Haemophilia is a rare hereditary haemorrhagic disease that requires regular intravenous injections of clotting factor (CF) concentrates. This study sought to estimate the health and economic burden of haemophilia in Belgium. This is the first study of its type to be conducted, and reflec...
Autores principales: | Henrard, Séverine, Devleesschauwer, Brecht, Beutels, Philippe, Callens, Michael, De Smet, Frank, Hermans, Cedric, Speybroeck, Niko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3998193/ https://www.ncbi.nlm.nih.gov/pubmed/24655371 http://dx.doi.org/10.1186/1750-1172-9-39 |
Ejemplares similares
-
Lyme borreliosis in Belgium: a cost-of-illness analysis
por: Geebelen, Laurence, et al.
Publicado: (2022) -
The direct disease burden of COVID-19 in Belgium in 2020 and 2021
por: Devleesschauwer, Brecht, et al.
Publicado: (2023) -
The state of health in Belgium, 1990–2019: a benchmarking analysis based on the Global Burden of Disease 2019 study
por: Ghattas, Jinane, et al.
Publicado: (2022) -
Quantifying burden of disease to support public health policy in Belgium: opportunities and constraints
por: Devleesschauwer, Brecht, et al.
Publicado: (2014) -
Burden of salmonellosis, campylobacteriosis and listeriosis: a time series analysis, Belgium, 2012 to 2020
por: Maertens de Noordhout, Charline, et al.
Publicado: (2017)